On September 24, 2010
You Can Blame Bristol-Myers’ Layoffs on Failed Launch of Me-Too Diabetes Drug
BMS had every reason to believe that the launch of Onglyza might come to its rescue, but the company is suffering because it refuses to engage in a price war.
No tags for this post.
0 Comments